BRAF mutations and translocations have been described in melanocytic nevi, malignant melanoma, colon adenocarcinoma, glioblastoma and pilocytic astrocytoma [38, 39] and EGFR mutations, amplifications in lung adenocarcinoma and brain tumors [40–42]. This evidence concerns the gene BRAF and lung adenocarcinoma.